- Home
- PLRX vs HKD Comparison
PLRX vs HKD Comparison
Compare PLRX & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLRX | HKD |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 487.1M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PLRX | HKD |
|---|---|---|
| Price | $1.24 | $1.37 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $3.79 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 511.0K |
| Earning Date | 11-06-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $87,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $1.33 |
| 52 Week High | $15.00 | $5.47 |
Technical Indicators
Market Signals| Indicator | PLRX | HKD |
|---|---|---|
| Relative Strength Index (RSI) | 35.98 | 38.97 |
| Support Level | $1.19 | $1.33 |
| Resistance Level | $1.30 | $1.43 |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 16.25 | 12.46 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.